Bove Mauro 4
4 · REGENERX BIOPHARMACEUTICALS INC · Filed May 15, 2019
Insider Transaction Report
Form 4
Bove Mauro
Director
Transactions
- Purchase
Convertible Promissory Note (right to buy)
2019-05-13$5000.00/shExercise: $0.12From: 2019-05-13Exp: 2024-05-13→ Common Stock (41,667 underlying) - Purchase
Common Stock Warrant (right to buy)
2019-05-13+31,250→ 31,250 totalExercise: $0.18From: 2019-11-13Exp: 2024-05-13→ Common Stock (31,250 underlying)
Holdings
- 150,000
Stock Option (right to buy)
Exercise: $0.21Exp: 2021-03-25→ Common Stock (150,000 underlying) - 100,000
Stock Option (right to buy)
Exercise: $0.19Exp: 2022-02-11→ Common Stock (100,000 underlying) - 100,000
Stock Option (right to buy)
Exercise: $0.36Exp: 2022-06-30→ Common Stock (100,000 underlying) - 100,000
Stock Option (right to buy)
Exercise: $0.64Exp: 2023-03-16→ Common Stock (100,000 underlying) - 125,000
Stock Option (right to buy)
Exercise: $0.28Exp: 2027-09-01→ Common Stock (125,000 underlying) - 200,000
Stock Option (right to buy)
Exercise: $0.21Exp: 2028-07-17→ Common Stock (200,000 underlying) Convertible Promissory Note (right to buy)
Exercise: $0.12From: 2019-02-27Exp: 2024-02-27→ Common Stock (41,667 underlying)- 31,250
Common Stock Warrant (right to buy)
Exercise: $0.18From: 2019-08-27Exp: 2024-02-27→ Common Stock (31,250 underlying)
Footnotes (4)
- [F1]100% vested.
- [F2]25,000 shares vest on each of 3/16/16, 3/16/17, 3/16/18 and 3/16/19.
- [F3]31,250 shares vest on each of 9/1/17, 9/1/18, 9/1/19 and 9/1/20.
- [F4]50,000 shares vest on each of 7/17/18, 7/17/19, 7/17/20 and 7/17/21.